$Moderna, _老虎社区_美港股上老虎

台灣路易
2021-02-02

$Moderna, Inc.(MRNA)$$美國銀行(BAC)$想買要說啊不要那麼傲嬌

Bank of America downgrades Moderna stock over concerns about valuation

MW Bank of America downgrades Moderna stock over concerns about valuation Shares of Moderna Inc. (MRNA) tumbled 8.2% in trading on Monday after Bank of America analysts downgraded the company's st

Bank of America downgrades Moderna stock over concerns about valuation

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

每年翻倍戰士
·2021-02-09
又被你說對了😳
回复
1
举报
收起
- 台灣路易:
  還不追蹤起來
  2021-02-09
  回复
  举报
心态一个
·2021-02-03
美国银行，美国航空自己都跌成什么样了，
回复
1
举报
收起
- 台灣路易:
  兩者有關係嗎🤔️
  2021-02-03
  回复
  举报

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":315830561,"tweetId":"315830561","gmtCreate":1612229321953,"gmtModify":1703759037024,"author":{"id":3569278572505099,"idStr":"3569278572505099","authorId":3569278572505099,"authorIdStr":"3569278572505099","name":"台灣路易","avatar":"https://static.tigerbbs.com/35040101e8dec6b6597b0cc08536598d","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":22,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a><a href=\"https://laohu8.com/S/BAC\">$美國銀行(BAC)$</a>想買要說啊不要那麼傲嬌</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a><a href=\"https://laohu8.com/S/BAC\">$美國銀行(BAC)$</a>想買要說啊不要那麼傲嬌</p></body></html>","text":"$Moderna, Inc.(MRNA)$$美國銀行(BAC)$想買要說啊不要那麼傲嬌","highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":7,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/315830561","repostId":2108520936,"repostType":2,"repost":{"id":"2108520936","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1612209900,"share":"https://www.laohu8.com/m/news/2108520936?lang=&edition=full","pubTime":"2021-02-02 04:05","market":"hk","language":"en","title":"Bank of America downgrades Moderna stock over concerns about valuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2108520936","media":"Dow Jones","summary":"MW Bank of America downgrades Moderna stock over concerns about valuation     Shares of Moderna Inc. (MRNA) tumbled 8.2% in trading on Monday after Bank of America analysts downgraded the company's st","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Bank of America downgrades Moderna stock over concerns about valuation\n</p>\n<p>\n  Shares of Moderna Inc. <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> tumbled 8.2% in trading on Monday after Bank of America analysts downgraded the company's stock to underperform from neutral, citing valuation concerns. Until December, Moderna was a clinical-stage company that had yet to bring to market a single therapy, but it now has <a href=\"https://laohu8.com/S/AONE\">one</a> of two authorized COVID-19 vaccines in the U.S. The company's stock is up 52.7% so far this year and has soared 677.6% over the past 12 months. Moderna \"shares continue to run...attaining levels that are increasingly difficult to justify on a fundamental basis,\" the Bank of America analysts wrote in a Feb. 1 note to investors. They estimate that Moderna's COVID-19 vaccine will have about 14% of the COVID-19 vaccine market in the U.S. and Europe, and it will generate peak sales of $12.8 billion in 2022, a sales figure that is expected to decline to less than $1 billion by 2027. The emergence of two other viable COVID-19 vaccine candidates, which are being developed by Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> and Novavax Inc. <a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a>, also cut into analyst expectations, though neither experimental vaccine has received emergency use authorization from the Food and Drug Administration or has so far reported efficacy rates as high as Moderna or <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> (BNTX)/Pfizer Inc.'s <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> vaccines. \"The number of vaccine options with compelling characteristics (single injection, lower cost, clean safety) could begin to weigh on Moderna's margins and market share longer-term,\" Bank of America analysts concluded. The S&amp;P 500  is up 13.5% over the last 12 months. \n</p>\n<p>\n  -Jaimy Lee; 415-439-6400; AskNewswires@dowjones.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  February 01, 2021 15:05 ET (20:05 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bank of America downgrades Moderna stock over concerns about valuation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBank of America downgrades Moderna stock over concerns about valuation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-02-02 04:05</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Bank of America downgrades Moderna stock over concerns about valuation\n</p>\n<p>\n  Shares of Moderna Inc. <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> tumbled 8.2% in trading on Monday after Bank of America analysts downgraded the company's stock to underperform from neutral, citing valuation concerns. Until December, Moderna was a clinical-stage company that had yet to bring to market a single therapy, but it now has <a href=\"https://laohu8.com/S/AONE\">one</a> of two authorized COVID-19 vaccines in the U.S. The company's stock is up 52.7% so far this year and has soared 677.6% over the past 12 months. Moderna \"shares continue to run...attaining levels that are increasingly difficult to justify on a fundamental basis,\" the Bank of America analysts wrote in a Feb. 1 note to investors. They estimate that Moderna's COVID-19 vaccine will have about 14% of the COVID-19 vaccine market in the U.S. and Europe, and it will generate peak sales of $12.8 billion in 2022, a sales figure that is expected to decline to less than $1 billion by 2027. The emergence of two other viable COVID-19 vaccine candidates, which are being developed by Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> and Novavax Inc. <a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a>, also cut into analyst expectations, though neither experimental vaccine has received emergency use authorization from the Food and Drug Administration or has so far reported efficacy rates as high as Moderna or <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> (BNTX)/Pfizer Inc.'s <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> vaccines. \"The number of vaccine options with compelling characteristics (single injection, lower cost, clean safety) could begin to weigh on Moderna's margins and market share longer-term,\" Bank of America analysts concluded. The S&amp;P 500  is up 13.5% over the last 12 months. \n</p>\n<p>\n  -Jaimy Lee; 415-439-6400; AskNewswires@dowjones.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  February 01, 2021 15:05 ET (20:05 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞","BNTX":"BioNTech SE","JNJ":"强生","NVAX":"诺瓦瓦克斯医药","BAC":"美国银行"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108520936","content_text":"MW Bank of America downgrades Moderna stock over concerns about valuation\n\n\n  Shares of Moderna Inc. $(MRNA)$ tumbled 8.2% in trading on Monday after Bank of America analysts downgraded the company's stock to underperform from neutral, citing valuation concerns. Until December, Moderna was a clinical-stage company that had yet to bring to market a single therapy, but it now has one of two authorized COVID-19 vaccines in the U.S. The company's stock is up 52.7% so far this year and has soared 677.6% over the past 12 months. Moderna \"shares continue to run...attaining levels that are increasingly difficult to justify on a fundamental basis,\" the Bank of America analysts wrote in a Feb. 1 note to investors. They estimate that Moderna's COVID-19 vaccine will have about 14% of the COVID-19 vaccine market in the U.S. and Europe, and it will generate peak sales of $12.8 billion in 2022, a sales figure that is expected to decline to less than $1 billion by 2027. The emergence of two other viable COVID-19 vaccine candidates, which are being developed by Johnson & Johnson $(JNJ)$ and Novavax Inc. $(NVAX)$, also cut into analyst expectations, though neither experimental vaccine has received emergency use authorization from the Food and Drug Administration or has so far reported efficacy rates as high as Moderna or BioNTech SE (BNTX)/Pfizer Inc.'s $(PFE)$ vaccines. \"The number of vaccine options with compelling characteristics (single injection, lower cost, clean safety) could begin to weigh on Moderna's margins and market share longer-term,\" Bank of America analysts concluded. The S&P 500  is up 13.5% over the last 12 months. \n\n\n  -Jaimy Lee; 415-439-6400; AskNewswires@dowjones.com \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  February 01, 2021 15:05 ET (20:05 GMT)\n\n\n  Copyright (c) 2021 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1986,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["BAC","MRNA"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":57,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":3523610,"commentId":"3523610","gmtCreate":1612848232654,"gmtModify":1612848232654,"authorId":3499863603243208,"author":{"id":3499863603243208,"idStr":"3499863603243208","authorId":3499863603243208,"name":"每年翻倍戰士","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":315830561,"objectIdStr":"315830561","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"又被你說對了😳","text":"又被你說對了😳","html":"又被你說對了😳","likeSize":1,"commentSize":1,"subComments":[{"id":3524171,"commentId":"3524171","gmtCreate":1612856459419,"gmtModify":1612856459419,"authorId":3569278572505099,"author":{"id":3569278572505099,"idStr":"3569278572505099","authorId":3569278572505099,"name":"台灣路易","avatar":"https://static.tigerbbs.com/35040101e8dec6b6597b0cc08536598d","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":315830561,"objectIdStr":"315830561","type":1,"supId":3523610,"supIdStr":"3523610","prevId":0,"prevIdStr":"0","content":"還不追蹤起來","text":"還不追蹤起來","html":"還不追蹤起來"}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":3472384,"commentId":"3472384","gmtCreate":1612298261438,"gmtModify":1612298261438,"authorId":3551437355244169,"author":{"id":3551437355244169,"idStr":"3551437355244169","authorId":3551437355244169,"name":"心态一个","avatar":"https://static.tigerbbs.com/aec02038e72190631add6bc5413f88b2","vip":1,"currentWearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.93%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":315830561,"objectIdStr":"315830561","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"美国银行，美国航空自己都跌成什么样了，","text":"美国银行，美国航空自己都跌成什么样了，","html":"美国银行，美国航空自己都跌成什么样了，","likeSize":1,"commentSize":1,"subComments":[{"id":3474842,"commentId":"3474842","gmtCreate":1612322250894,"gmtModify":1612322250894,"authorId":3569278572505099,"author":{"id":3569278572505099,"idStr":"3569278572505099","authorId":3569278572505099,"name":"台灣路易","avatar":"https://static.tigerbbs.com/35040101e8dec6b6597b0cc08536598d","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":315830561,"objectIdStr":"315830561","type":1,"supId":3472384,"supIdStr":"3472384","prevId":0,"prevIdStr":"0","content":"兩者有關係嗎🤔️","text":"兩者有關係嗎🤔️","html":"兩者有關係嗎🤔️"}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}

Bank of America downgrades Moderna stock over concerns about valuation

评论（7）

热议股票